Rapport Therapeutics (RAPP) Interest Coverage Ratio (2023 - 2026)

Rapport Therapeutics (RAPP) has 4 years of Interest Coverage Ratio data on file, last reported at 0.2 in Q1 2026.

• On a quarterly basis, Interest Coverage Ratio fell 8689.82% year-over-year to 0.2 in Q1 2026; TTM through Mar 2026 was 0.99, a 12820.53% decrease from a year earlier, with the FY2025 full-year figure at 1.1, up 54.59% from the prior year.
• Interest Coverage Ratio for Q1 2026 stood at 0.2, up from 0.34 in the prior quarter.
• Over the last five years, Interest Coverage Ratio for RAPP reached as high as 0.0 in Q1 2025 and fell as low as 1.76 in Q2 2025.
• Historically, Interest Coverage Ratio has averaged 0.59 across 4 years, with a median of 0.43 in 2024.
• Across the five-year window, Interest Coverage Ratio soared 50.64% in 2025 and tumbled 8689.82% in 2026, its largest moves.
• Year by year, Interest Coverage Ratio stood at 1.13 in 2023, then surged by 39.11% to 0.69 in 2024, then surged by 50.64% to 0.34 in 2025, then surged by 42.19% to 0.2 in 2026.
• Per Business Quant data, the three most recent Interest Coverage Ratio figures were 0.2 in Q1 2026, 0.34 in Q4 2025, and 0.27 in Q3 2025.